课题基金 / 基金详情

Application of the molecular understanding of high density lipoprotein biogenesis to provide surrogate endpoints for use in an atherosclerosis therapy study

Application of the molecular understanding of high density lipoprotein biogenesis to provide surrogate endpoints for use in an atherosclerosis therapy study
应用高密度脂蛋白生物发生的分子理解为动脉粥样硬化治疗研究提供替代终点
批准号：
184571
负责人：
Bailey Dana
金额：
$1.52万
依托单位：
McGill University
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2008
资助国家：
加拿大
项目状态：
已结题
起止时间：
2008-11-01 至 2009-04-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=184571&lang=en
关键词：
2d Pagge Abc Transporters Animal Study/Rabbit Model Atherosclerosis Cell Culture Cell Signaling Pathways Cellular Cholesterol Efflux Hdl Remodeling And Metabolism High Density Lipoprotein (Hdl) Therapeutic/Clinical Potential

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Cardiovascular disease remains the number one cause of death worldwide. High density lipoprotein (HDL) particles, often referred to as "good cholesterol", are believed to protect against cardiovascular disease by several mechanisms. For the past 18 years,
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金